首页 > 最新文献

Metal-Based Drugs最新文献

英文 中文
Anticancer Activity of Ag(I) N-Heterocyclic Carbene Complexes Derived from 4,5-Dichloro-1H-Imidazole. 4,5-二氯- 1h -咪唑衍生银(I) n -杂环卡贝配合物的抗癌活性
Pub Date : 2008-01-01 DOI: 10.1155/2008/384010
Doug A Medvetz, Khadijah M Hindi, Matthew J Panzner, Andrew J Ditto, Yang H Yun, Wiley J Youngs

A class of Ag(I) N-heterocyclic carbene silver complexes, 1-3, derived from 4,5-dichloro-1H-imidazole has been evaluated for their anticancer activity against the human cancer cell lines OVCAR-3 (ovarian), MB157 (breast), and Hela (cervical). Silver complexes 1-3 are active against the ovarian and breast cancer cell lines. A preliminary in vivo study shows 1 to be active against ovarian cancer in mice. The results obtained in these studies warrant further investigation of these compounds in vivo.

一类由4,5-二氯- 1h -咪唑衍生的Ag(I) n -杂环碳银配合物1-3对人卵巢癌OVCAR-3、乳腺癌MB157和宫颈癌Hela细胞的抗癌活性进行了评价。银复合物1-3对卵巢癌和乳腺癌细胞系有活性。一项初步的体内研究表明,1对小鼠卵巢癌有活性。在这些研究中获得的结果证明了这些化合物在体内的进一步研究。
{"title":"Anticancer Activity of Ag(I) N-Heterocyclic Carbene Complexes Derived from 4,5-Dichloro-1H-Imidazole.","authors":"Doug A Medvetz,&nbsp;Khadijah M Hindi,&nbsp;Matthew J Panzner,&nbsp;Andrew J Ditto,&nbsp;Yang H Yun,&nbsp;Wiley J Youngs","doi":"10.1155/2008/384010","DOIUrl":"https://doi.org/10.1155/2008/384010","url":null,"abstract":"<p><p>A class of Ag(I) N-heterocyclic carbene silver complexes, 1-3, derived from 4,5-dichloro-1H-imidazole has been evaluated for their anticancer activity against the human cancer cell lines OVCAR-3 (ovarian), MB157 (breast), and Hela (cervical). Silver complexes 1-3 are active against the ovarian and breast cancer cell lines. A preliminary in vivo study shows 1 to be active against ovarian cancer in mice. The results obtained in these studies warrant further investigation of these compounds in vivo.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"2008 ","pages":"384010"},"PeriodicalIF":0.0,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2008/384010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9743287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 119
Receptor-drug interaction: europium employment for studying the biochemical pathway of g-protein-coupled receptor activation. 受体-药物相互作用:研究g蛋白偶联受体激活的生化途径的铕就业。
Pub Date : 2007-01-01 DOI: 10.1155/2007/12635
Colabufo Nicola Antonio, Perrone Maria Grazia, Contino Marialessandra, Berardi Francesco, Perrone Roberto

In medicinal chemistry field, the biochemical pathways, involved in 7-transmembrane domains G-protein coupled receptors (GPCRs) activation, are commonly studied to establish the activity of ligands towards GPCRs. The most studied steps are the measurement of activated GTP-alpha subunit and stimulated intracellular cAMP. At the present, many researchers defined agonist or antagonist activity of potential GPCRs drugs employing [(35)S]GTPgammaS or [(3)H]cAMP as probes. Recently, the corresponding lanthanide labels Eu-GTP and Eu-cAMP as alternative to radiochemicals have been developed because they are highly sensitive, easy to automate, easily synthesized, they display a much longer shelf-life and they can be used in multilabel experiments. In the present review, the receptor-drug interaction by europium employment for studying the biochemical pathway of GPCR activation has been focused. Moreover, comparative studies between lanthanide label probes and the corresponding radiolabeled compounds have been carried out.

在药物化学领域,通常研究7-跨膜结构域g蛋白偶联受体(gpcr)激活的生化途径,以确定配体对gpcr的活性。研究最多的步骤是测量活化的gtp - α亚基和刺激的细胞内cAMP。目前,许多研究者使用[(35)S]GTPgammaS或[(3)H]cAMP作为探针来定义潜在gpcr药物的激动剂或拮抗剂活性。近年来,铕- gtp和铕- camp作为放射性化学物质的替代品,具有灵敏度高、易于自动化、易于合成、保质期长、可用于多标签实验等特点。本文主要从受体与药物相互作用的角度研究铕活化GPCR的生化途径。此外,还对镧系标记探针与相应的放射性标记化合物进行了比较研究。
{"title":"Receptor-drug interaction: europium employment for studying the biochemical pathway of g-protein-coupled receptor activation.","authors":"Colabufo Nicola Antonio,&nbsp;Perrone Maria Grazia,&nbsp;Contino Marialessandra,&nbsp;Berardi Francesco,&nbsp;Perrone Roberto","doi":"10.1155/2007/12635","DOIUrl":"https://doi.org/10.1155/2007/12635","url":null,"abstract":"<p><p>In medicinal chemistry field, the biochemical pathways, involved in 7-transmembrane domains G-protein coupled receptors (GPCRs) activation, are commonly studied to establish the activity of ligands towards GPCRs. The most studied steps are the measurement of activated GTP-alpha subunit and stimulated intracellular cAMP. At the present, many researchers defined agonist or antagonist activity of potential GPCRs drugs employing [(35)S]GTPgammaS or [(3)H]cAMP as probes. Recently, the corresponding lanthanide labels Eu-GTP and Eu-cAMP as alternative to radiochemicals have been developed because they are highly sensitive, easy to automate, easily synthesized, they display a much longer shelf-life and they can be used in multilabel experiments. In the present review, the receptor-drug interaction by europium employment for studying the biochemical pathway of GPCR activation has been focused. Moreover, comparative studies between lanthanide label probes and the corresponding radiolabeled compounds have been carried out.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"2007 ","pages":"12635"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2007/12635","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27329424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Synthesis, Structural Characterization, and Cytotoxic Activity of Novel Paramagnetic Platinum Hematoporphyrin IX Complexes: Potent Antitumor Agents. 新型顺磁性铂类血卟啉IX配合物的合成、结构表征和细胞毒活性:有效的抗肿瘤药物。
Pub Date : 2007-01-01 DOI: 10.1155/2007/67376
G Gencheva, D Tsekova, G Gochev, G Momekov, G Tyuliev, V Skumryev, M Karaivanova, P R Bontchev

Three novel stable Pt(III) complexes with distorted octahedral structure and (dz2)1 ground state have been obtained in the course of Pt(II)-hematoporphyrin IX ((7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H-23H-porphyn-2,18-dipropionic acid), Hp) interaction in alkaline aqueous medium and aerobic conditions. A redox interaction also takes place together with the complexation process leading to the formation of Pt(III) species and organic radicals. The processes in the reaction system and the structure of the complexes formed cis-[Pt(III)(NH3)2(Hp-3H)(H2O)2]H2O1, [Pt(III)(Hp-3H)(H2O)2]H2O2, and [Pt((O,O)Hp-2H)Cl(H2O)3] 3, were studied by UV-Vis, IR, EPR and XPS spectra, thermal (TGS, DSC), potentiometric and magnetic methods. The newly synthesized complexes show promising cytotoxic activity comparable with that of cis-platin in in vitro tests against a panel of human leukemia cell lines. The observed cytotoxicity of the complex 2 against SKW-3 cells (KE-37 derivative) is due to induction of cell death through apoptosis.

在碱性和好氧条件下,Pt(II)-血卟啉IX((7,12-双(1-羟乙基)-3,8,13,17-四甲基- 21h - 23h -卟啉-2,18-二丙酸),Hp)相互作用获得了三种具有畸变八面体结构和(dz2)1基态的新型稳定Pt(III)配合物。与络合过程一起发生氧化还原相互作用,导致Pt(III)物种和有机自由基的形成。采用紫外可见光谱、红外光谱、EPR和XPS光谱、热谱(TGS、DSC)、电位和磁谱等方法研究了反应体系中的反应过程和形成的顺式[Pt(III)(NH3)2(Hp-3H)(H2O)2] H2O2、[Pt(III)(Hp-3H)(H2O)2]H2O2和[Pt((O,O)Hp-2H)Cl(H2O)3] 3配合物的结构。新合成的复合物在对一组人类白血病细胞系的体外试验中显示出与顺铂相当的有希望的细胞毒性活性。观察到复合物2对SKW-3细胞(KE-37衍生物)的细胞毒性是由于通过凋亡诱导细胞死亡。
{"title":"Synthesis, Structural Characterization, and Cytotoxic Activity of Novel Paramagnetic Platinum Hematoporphyrin IX Complexes: Potent Antitumor Agents.","authors":"G Gencheva,&nbsp;D Tsekova,&nbsp;G Gochev,&nbsp;G Momekov,&nbsp;G Tyuliev,&nbsp;V Skumryev,&nbsp;M Karaivanova,&nbsp;P R Bontchev","doi":"10.1155/2007/67376","DOIUrl":"https://doi.org/10.1155/2007/67376","url":null,"abstract":"<p><p>Three novel stable Pt(III) complexes with distorted octahedral structure and (dz2)1 ground state have been obtained in the course of Pt(II)-hematoporphyrin IX ((7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H-23H-porphyn-2,18-dipropionic acid), Hp) interaction in alkaline aqueous medium and aerobic conditions. A redox interaction also takes place together with the complexation process leading to the formation of Pt(III) species and organic radicals. The processes in the reaction system and the structure of the complexes formed cis-[Pt(III)(NH3)2(Hp-3H)(H2O)2]H2O1, [Pt(III)(Hp-3H)(H2O)2]H2O2, and [Pt((O,O)Hp-2H)Cl(H2O)3] 3, were studied by UV-Vis, IR, EPR and XPS spectra, thermal (TGS, DSC), potentiometric and magnetic methods. The newly synthesized complexes show promising cytotoxic activity comparable with that of cis-platin in in vitro tests against a panel of human leukemia cell lines. The observed cytotoxicity of the complex 2 against SKW-3 cells (KE-37 derivative) is due to induction of cell death through apoptosis.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"2007 ","pages":"67376"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2007/67376","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27296153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
New Samarium(III), Gadolinium(III), and Dysprosium(III) Complexes of Coumarin-3-Carboxylic Acid as Antiproliferative Agents. 香豆素-3-羧酸的新型钐(III)、钆(III)和镝(III)配合物的抗增殖作用。
Pub Date : 2007-01-01 DOI: 10.1155/2007/15925
Irena Kostova, Georgi Momekov, Peya Stancheva

New complexes of samarium(III), gadolinium(III), and dysprosium(III) with coumarin-3-carboxylic acid (HCCA) were prepared by the reaction of the ligand with respective metal nitrates in ethanol. The structures of the final complexes were determined by means of physicochemical data, elemental analysis, IR and Raman spectra. The metal-ligand binding mode in the new Ln(III) complexes of coumarin-3-carboxylic acid was elucidated. The vibrational study gave evidence for bidentate coordination of CCA(-) to Ln(III) ions through the carbonylic oxygen and the carboxylic oxygen atoms. The complexes were tested for antiproliferative activitiy on the chronic myeloid leukemia-derived K-562, overexpressing the BCR-ABL fusion protein. Cytotoxicity towards tumor cells was determined for a broad concentration range. The samarium salt exerted a very weak antiproliferative effect on these cells. This is in contrast to the lanthanide complexes, especially samarium complex, which exhibited potent antiproliferative activity. The present study confirms our previous observations that the lanthanide complexes of coumarins exhibit antiproliferative activity towards K-562 cell line.

以香豆素-3-羧酸(HCCA)为配体,分别与金属硝酸盐在乙醇中反应制备了钐(III)、钆(III)和镝(III)的配合物。通过理化数据、元素分析、红外光谱和拉曼光谱等手段确定了最终配合物的结构。研究了香豆素-3-羧酸新型Ln(III)配合物的金属-配体结合模式。振动研究证明了CCA(-)与Ln(III)离子通过羰基氧和羧基氧原子进行双齿配位。这些复合物对过表达BCR-ABL融合蛋白的慢性髓系白血病源性K-562的抗增殖活性进行了测试。在较宽的浓度范围内测定了对肿瘤细胞的细胞毒性。钐盐对这些细胞的抗增殖作用很弱。这与镧系配合物,特别是钐配合物相反,镧系配合物表现出强大的抗增殖活性。本研究证实了我们先前观察到的香豆素镧系复合物对K-562细胞株具有抗增殖活性。
{"title":"New Samarium(III), Gadolinium(III), and Dysprosium(III) Complexes of Coumarin-3-Carboxylic Acid as Antiproliferative Agents.","authors":"Irena Kostova,&nbsp;Georgi Momekov,&nbsp;Peya Stancheva","doi":"10.1155/2007/15925","DOIUrl":"https://doi.org/10.1155/2007/15925","url":null,"abstract":"<p><p>New complexes of samarium(III), gadolinium(III), and dysprosium(III) with coumarin-3-carboxylic acid (HCCA) were prepared by the reaction of the ligand with respective metal nitrates in ethanol. The structures of the final complexes were determined by means of physicochemical data, elemental analysis, IR and Raman spectra. The metal-ligand binding mode in the new Ln(III) complexes of coumarin-3-carboxylic acid was elucidated. The vibrational study gave evidence for bidentate coordination of CCA(-) to Ln(III) ions through the carbonylic oxygen and the carboxylic oxygen atoms. The complexes were tested for antiproliferative activitiy on the chronic myeloid leukemia-derived K-562, overexpressing the BCR-ABL fusion protein. Cytotoxicity towards tumor cells was determined for a broad concentration range. The samarium salt exerted a very weak antiproliferative effect on these cells. This is in contrast to the lanthanide complexes, especially samarium complex, which exhibited potent antiproliferative activity. The present study confirms our previous observations that the lanthanide complexes of coumarins exhibit antiproliferative activity towards K-562 cell line.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"2007 ","pages":"15925"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2007/15925","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27264931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 54
Antimicrobial Study of Newly Synthesized Lanthanide(III) Complexes of 2-[2-hydroxy-3-methoxyphenyl]-3-[2-hydroxy-3-methoxybenzylamino]-1,2-dihydroquinazolin-4(3H)-one. 新合成镧系化合物(III) 2-[2-羟基-3-甲氧基苯基]-3-[2-羟基-3-甲氧基苯胺]-1,2-二氢喹唑啉-4(3H)- 1的抗菌研究
Pub Date : 2007-01-01 DOI: 10.1155/2007/37348
Kalagouda B Gudasi, Vidyadhar C Havanur, Siddappa A Patil, Basavaraj R Patil

New lanthanide(III) complexes with 2-[2-hydroxy-3-methoxyphenyl]-3-[hydroxyl-3-methoxybenzylamino]-1,2-dihydroquin- azoline-4(3H)-one (Hmpbaq) have been synthesized and characterized by elemental analysis, conductance measurements, magnetic susceptibilities, spectroscopic (IR, NMR, UV, EPR), and thermal studies. Molar conductance studies indicate 1 : 1 electrolytic behavior for these complexes. IR spectra indicate that Hmpbaq acts as a tridentate ligand coordinating through carbonyl oxygen, benzyl amine nitrogen, and deprotonated phenolic oxygen. TG and DTA studies of La(III) and Pr(III) complexes indicate the presence of two coordinated water molecules. Based on these studies, the complexes have been formulated as [La(mpbaq)(2)(H(2)O)(2)].NO(3), where Ln = La(III), Pr(III), Nd(III), Sm(III), Eu(III), Gd(III), Th(III), Dy(III), and Y(III). The ligand, lanthanide(III) salts, and the corresponding complexes have been simultaneously screened for their antibacterial and antifungal activities and compared with the drugs in use.

合成了2-[2-羟基-3-甲氧基苯基]-3-[羟基-3-甲氧基苯基氨基]-1,2-二氢喹啉-4(3H)- 1 (Hmpbaq)的镧系(III)配合物,并通过元素分析、电导测量、磁化率、光谱(IR、NMR、UV、EPR)和热研究对其进行了表征。摩尔电导研究表明,这些配合物具有1:1的电解行为。红外光谱表明,Hmpbaq是一种通过羰基氧、苯胺氮和去质子化酚氧配位的三叉戟配体。La(III)和Pr(III)配合物的TG和DTA研究表明存在两个配位的水分子。基于这些研究,这些配合物被表示为[La(mpbaq)(2)(H(2)O)(2)]. no(3),其中Ln = La(III)、Pr(III)、Nd(III)、Sm(III)、Eu(III)、Gd(III)、Th(III)、Dy(III)和Y(III)。同时对配体、镧系(III)盐及其配合物的抗菌和抗真菌活性进行了筛选,并与目前使用的药物进行了比较。
{"title":"Antimicrobial Study of Newly Synthesized Lanthanide(III) Complexes of 2-[2-hydroxy-3-methoxyphenyl]-3-[2-hydroxy-3-methoxybenzylamino]-1,2-dihydroquinazolin-4(3H)-one.","authors":"Kalagouda B Gudasi,&nbsp;Vidyadhar C Havanur,&nbsp;Siddappa A Patil,&nbsp;Basavaraj R Patil","doi":"10.1155/2007/37348","DOIUrl":"https://doi.org/10.1155/2007/37348","url":null,"abstract":"<p><p>New lanthanide(III) complexes with 2-[2-hydroxy-3-methoxyphenyl]-3-[hydroxyl-3-methoxybenzylamino]-1,2-dihydroquin- azoline-4(3H)-one (Hmpbaq) have been synthesized and characterized by elemental analysis, conductance measurements, magnetic susceptibilities, spectroscopic (IR, NMR, UV, EPR), and thermal studies. Molar conductance studies indicate 1 : 1 electrolytic behavior for these complexes. IR spectra indicate that Hmpbaq acts as a tridentate ligand coordinating through carbonyl oxygen, benzyl amine nitrogen, and deprotonated phenolic oxygen. TG and DTA studies of La(III) and Pr(III) complexes indicate the presence of two coordinated water molecules. Based on these studies, the complexes have been formulated as [La(mpbaq)(2)(H(2)O)(2)].NO(3), where Ln = La(III), Pr(III), Nd(III), Sm(III), Eu(III), Gd(III), Th(III), Dy(III), and Y(III). The ligand, lanthanide(III) salts, and the corresponding complexes have been simultaneously screened for their antibacterial and antifungal activities and compared with the drugs in use.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"2007 ","pages":"37348"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2007/37348","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27296155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 34
Metal based drugs restyled and resumed. 以金属为基础的药物重新设计和恢复。
Pub Date : 2007-01-01 DOI: 10.1155/2007/16260
Gianni Sava
This is the first issue of Metal Based Drugs, our journal, restyled and resumed after 5 years' silence. A number of distinguished scientists have agreed to be Associate Editors and to assist in the new course of this multidisciplinary journal, to encourage it to survive and to be the forum where to post the most important findings of our intriguing research of new and innovative metal-based drugs. With your help, the journal has an excellent potential to rapidly become the most important reference in the biomedical literature of drugs for diseases such as cancer and diabetes or for diagnostics based on the modern molecular approach formetals in biology and medicine. Undoubtedly, of the many fields where metals can help medicine with innovative drugs, chemotherapy and particularly cancer chemotherapy is forever attracting considerable interest. In this context it is important to note that there is a decreasing interest in DNA-damaging drugs. Unlike the era initiated with the discovery of the anticancer activity of mechlorethamine in 1940s, it is more commonly accepted that the new golden era of cancer chemotherapy is driven by a new series of drugs characterized by their capacity to interact with targets expressed with high selectivity only by tumour cells and this is now giving rise to drugs that are actually available in clinical practice. It is clear that the “old drugs” will still accompany us in the clinical treatment of tumours for many years. It is similarly evident that the few improvements we may expect from these drugs (those acting on nucleic acids or on macromolecules of the mitotic spindle) are those associated with a better pharmacokinetic profile that can lead to the reduction of systemic toxicity, the main problem limiting the use of such drugs. Researchers are now convinced that targets such as DNA, RNA, and tubulin do not provide sufficient selectivity for cancer cells without negative effects on healthy tissues. Also, factors such as the high tendency to develop resistance towards chemotherapeutic agents, the genetic instability of tumour cells, their heterogeneity, and their elevated mutation index are elements sufficient to circumvent the practical application of chemotherapy. Furthermore, we now have new ways to develop and research ideas on the processes of gene regulation involved in tumour malignancy: activation and repression of signal transduction pathways depending on various extracellular signals and/or cellmutations that select their capacity to survive, generate tumours, and to invade and give rise to metastases, the ultimate target of chemotherapy. We therefore have important work to do: to obtain new metal-based drugs that are not related to cisplatin or platinum analogues currently in use or in the advanced stages of development, since these represent part of the old strategy of antitumour chemotherapy. We are conscious of the difficulties of the game but we will run this race with the important advantage
{"title":"Metal based drugs restyled and resumed.","authors":"Gianni Sava","doi":"10.1155/2007/16260","DOIUrl":"https://doi.org/10.1155/2007/16260","url":null,"abstract":"This is the first issue of Metal Based Drugs, our journal, restyled and resumed after 5 years' silence. A number of distinguished scientists have agreed to be Associate Editors and to assist in the new course of this multidisciplinary journal, to encourage it to survive and to be the forum where to post the most important findings of our intriguing research of new and innovative metal-based drugs. With your help, the journal has an excellent potential to rapidly become the most important reference in the biomedical literature of drugs for diseases such as cancer and diabetes or for diagnostics based on the modern molecular approach formetals in biology and medicine. \u0000 \u0000Undoubtedly, of the many fields where metals can help medicine with innovative drugs, chemotherapy and particularly cancer chemotherapy is forever attracting considerable interest. In this context it is important to note that there is a decreasing interest in DNA-damaging drugs. Unlike the era initiated with the discovery of the anticancer activity of mechlorethamine in 1940s, it is more commonly accepted that the new golden era of cancer chemotherapy is driven by a new series of drugs characterized by their capacity to interact with targets expressed with high selectivity only by tumour cells and this is now giving rise to drugs that are actually available in clinical practice. It is clear that the “old drugs” will still accompany us in the clinical treatment of tumours for many years. It is similarly evident that the few improvements we may expect from these drugs (those acting on nucleic acids or on macromolecules of the mitotic spindle) are those associated with a better pharmacokinetic profile that can lead to the reduction of systemic toxicity, the main problem limiting the use of such drugs. \u0000 \u0000Researchers are now convinced that targets such as DNA, RNA, and tubulin do not provide sufficient selectivity for cancer cells without negative effects on healthy tissues. Also, factors such as the high tendency to develop resistance towards chemotherapeutic agents, the genetic instability of tumour cells, their heterogeneity, and their elevated mutation index are elements sufficient to circumvent the practical application of chemotherapy. Furthermore, we now have new ways to develop and research ideas on the processes of gene regulation involved in tumour malignancy: activation and repression of signal transduction pathways depending on various extracellular signals and/or cellmutations that select their capacity to survive, generate tumours, and to invade and give rise to metastases, the ultimate target of chemotherapy. \u0000 \u0000We therefore have important work to do: to obtain new metal-based drugs that are not related to cisplatin or platinum analogues currently in use or in the advanced stages of development, since these represent part of the old strategy of antitumour chemotherapy. We are conscious of the difficulties of the game but we will run this race with the important advantage","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"2007 ","pages":"16260"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2007/16260","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27363335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solution Equilibria between Aluminum(III) Ion and L-histidine or L-tyrosine. 铝(III)离子与l -组氨酸或l -酪氨酸的溶液平衡。
Pub Date : 2002-01-01 DOI: 10.1155/MBD.2002.235
Predrag Djurdjevic, Ratomir Jelic, Dragana Dzajevic, Mirjana Cvijovic

Toxic effects due to high aluminum body loads were observed in a number of conditions following ingestion of Al-containing antacids. Bio-availability of aluminum depends not only on the solubility of the ingested salt but also on the physico-chemical properties of the soluble Al complexes formed in body fluids. Amino acids may, upon interaction with Al-salts, form absorbable Al-complexes. Hence, complex formation equilibria between Al(3+) and either, L- histidine or L-tyrosine were studied by glass electrode potentiometric (0.1 mol/L LiCl ionic medium, 298 K), proton NMR and uv spectrophotometric measurements. Non linear least squares treatment of the potentiometric data indicates that in the concentration ranges: 0.5

在摄入含铝抗酸剂后的一些情况下,观察到高铝体负荷的毒性作用。铝的生物利用度不仅取决于摄入盐的溶解度,还取决于在体液中形成的可溶铝络合物的物理化学性质。氨基酸与铝盐相互作用后,可形成可吸收的铝络合物。因此,采用玻璃电极电位法(0.1 mol/L LiCl离子介质,298 K)、质子核磁共振和紫外分光光度法研究了Al(3+)与L-组氨酸或L-酪氨酸之间的络合物形成平衡。非线性最小二乘处理的电位数据表明,在浓度范围:0.5
{"title":"Solution Equilibria between Aluminum(III) Ion and L-histidine or L-tyrosine.","authors":"Predrag Djurdjevic,&nbsp;Ratomir Jelic,&nbsp;Dragana Dzajevic,&nbsp;Mirjana Cvijovic","doi":"10.1155/MBD.2002.235","DOIUrl":"https://doi.org/10.1155/MBD.2002.235","url":null,"abstract":"<p><p>Toxic effects due to high aluminum body loads were observed in a number of conditions following ingestion of Al-containing antacids. Bio-availability of aluminum depends not only on the solubility of the ingested salt but also on the physico-chemical properties of the soluble Al complexes formed in body fluids. Amino acids may, upon interaction with Al-salts, form absorbable Al-complexes. Hence, complex formation equilibria between Al(3+) and either, L- histidine or L-tyrosine were studied by glass electrode potentiometric (0.1 mol/L LiCl ionic medium, 298 K), proton NMR and uv spectrophotometric measurements. Non linear least squares treatment of the potentiometric data indicates that in the concentration ranges: 0.5</=C(A1)</=2.0 ; 1.0</=C(His)</=10.0; 2.5</=PH</=6.5, in Al(3+) + His solutions, the following complexes (with log overall stability constants given in parenthesis) are formed: Al(HHis)(3+)(12.21+/-0.08); Al(His)(2+), (7.25+/-0.08); and Al(HHis)His(2+), (20.3+/-0.1). In Al(3+) + Tyr solutions in the concentration range 1.0</=C(Tyr)</=3.0 mmol/L and ligand to metal concentration ratio from 2:1 to 3:1, in the pH interval from 3.0 to 6.5 the formation of the following complexes was detected: Al(HTyr)(2+), (12.72+/-0.09); Al(Tyr)(2+), (10.16+/-0.03) and Al(OH)(2)Tyr , (2.70+/-0.05). Proton NMR data indicate that in Al(His)(2+) complex histidine acts as a monodentate ligand but its bidentate coordination is possible with carboxylate oxygen and imidazole 1-nitrogen as donors. In Al(HTyr)(3+) complex tyrosine is a monodentate ligand with carboxylate oxygen as donor. The mechanism of the formation of complexes in solution is discussed as well as their possible role in aluminum toxicity.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 5","pages":"235-48"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2002.235","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27437390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Growth Effects of Some Platinum(II) Complexes with Sulfur-Containing Carrier Ligands on MCF7 Human Breast Cancer Cell Line upon Simultaneous Administration with Taxol. 一些含硫载体配体铂(II)配合物与紫杉醇同时给药对MCF7人乳腺癌细胞系生长的影响
Pub Date : 2002-01-01 DOI: 10.1155/MBD.2002.33
Gordana Bogdanović, Vesna Kojić, Tatjana Srdić, Dimitar Jakimov, Milos I Djuran, Zivadin D Bugarcić, Mirjana Baltić, Vladimir V Baltić

The platinum (II)complexes, cis-[PtCl(2)(CH(3)SCH(2)CH(2)SCH(3))] (Pt1), cis-[PtCl(2)(dmso)(2)] (dmso is dimethylsulfoxide; Pt2) and cis-[PtCl(2)(NH(3))(2)] (cisplatin), and taxol (T) have been tested at different equimolar concentrations. Cells were exposed to complexes for 2 h and left to recover in fresh medium for 24, 48 or 72 h. Growth inhibition was measured by tetrazolium WST1 assay Analyses of the cell cycle, and apoptosis were performed by flow cytometry, at the same exposure times. The IC50 value of each platinum(II) complex as well as combination index (CI; platinum(II) complex + taxol) for various cytotoxicity levels were determined by median effects analysis.MCF7 cells were found to be sensitive to both Pt1 and Pt2 complexe These cisplatin analogues influenced the cell growth more effectively as compared to cisplatin. Cytotoxic effect was concentration and time-dependent. Profound growth inhibitory effect was observed for Pt1 complex, across all its concentrations at all recovery periods. A plateau effect was achieved three days after treatment at Pt1 concentrations

铂(II)配合物,顺式-[PtCl(2)(CH(3)SCH(2)CH(2)SCH(3))] (Pt1),顺式-[PtCl(2)(dmso)(2)] (dmso是二甲亚砜;Pt2)和顺式-[PtCl(2)(nh3))(2)](顺铂)和紫杉醇(T)在不同等摩尔浓度下进行了测试。将细胞暴露于复合物中2小时,然后在新鲜培养基中恢复24、48或72小时。在相同的暴露时间下,用四氮唑WST1测定生长抑制作用,用流式细胞术分析细胞周期和凋亡。各铂(II)配合物的IC50值及组合指数(CI;通过中位效应分析确定铂(II)配合物+紫杉醇的不同细胞毒性水平。MCF7细胞对Pt1和Pt2复合物均敏感。与顺铂相比,这些顺铂类似物对细胞生长的影响更有效。细胞毒作用具有浓度和时间依赖性。在所有恢复期,所有浓度的Pt1复合物都观察到深刻的生长抑制作用。Pt1浓度治疗后3天达到平台效应
{"title":"Growth Effects of Some Platinum(II) Complexes with Sulfur-Containing Carrier Ligands on MCF7 Human Breast Cancer Cell Line upon Simultaneous Administration with Taxol.","authors":"Gordana Bogdanović,&nbsp;Vesna Kojić,&nbsp;Tatjana Srdić,&nbsp;Dimitar Jakimov,&nbsp;Milos I Djuran,&nbsp;Zivadin D Bugarcić,&nbsp;Mirjana Baltić,&nbsp;Vladimir V Baltić","doi":"10.1155/MBD.2002.33","DOIUrl":"https://doi.org/10.1155/MBD.2002.33","url":null,"abstract":"<p><p>The platinum (II)complexes, cis-[PtCl(2)(CH(3)SCH(2)CH(2)SCH(3))] (Pt1), cis-[PtCl(2)(dmso)(2)] (dmso is dimethylsulfoxide; Pt2) and cis-[PtCl(2)(NH(3))(2)] (cisplatin), and taxol (T) have been tested at different equimolar concentrations. Cells were exposed to complexes for 2 h and left to recover in fresh medium for 24, 48 or 72 h. Growth inhibition was measured by tetrazolium WST1 assay Analyses of the cell cycle, and apoptosis were performed by flow cytometry, at the same exposure times. The IC50 value of each platinum(II) complex as well as combination index (CI; platinum(II) complex + taxol) for various cytotoxicity levels were determined by median effects analysis.MCF7 cells were found to be sensitive to both Pt1 and Pt2 complexe These cisplatin analogues influenced the cell growth more effectively as compared to cisplatin. Cytotoxic effect was concentration and time-dependent. Profound growth inhibitory effect was observed for Pt1 complex, across all its concentrations at all recovery periods. A plateau effect was achieved three days after treatment at Pt1 concentrations </= 1 muM. Pt2, however, decreased MCF7 cells survival only for the first 24 h ranging between 50-55%. Pt2 cytotoxicity sharply decreased thereafter, approaching 2 h - treatment cytotoxicity level. The median IC50 values for Pt1 and Pt2 were similar (0.337 and 0.3051 muM, respectively) but only for the first 24 h. The IC50 values for Pt1 strongly depend on the recovery period. On simultaneos exposure of cells to taxol and platinum(II) complexes no consistent effect was found. The Cls for combinations of taxol with Pt1 or Pt2 revealed cytotoxic effects that were in most Cases synergistic (Pt1) or less than addtiive (Pt2). Flow cytometry analysis has shown that each platinum(II) complex induced apoptosis in MCF7 cells. The level of apoptosis correlated with cytotoxicity level for the range concentrations. Both cisplatin analogues, at IC50 concentrations, increased the number of MCF7 cells in G0G1 phase of cell cycle. Pt2-treated cells remained arrested in G0G1 phase up to 72 h after treatment. Combination of Pt2 and taxol caused further arrest of cells in G0G1 phase (24 h) in parallel with strong decrement of G2M phase cells.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"9 1-2","pages":"33-43"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2002.33","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27437619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Antibacterial and Antifungal Activity of Zinc(II) Carboxylates With/Without N-Donor Organic Ligands. 含/不含n给体有机配体的锌(II)羧酸酯的抗菌和抗真菌活性
Pub Date : 2002-01-01 DOI: 10.1155/MBD.2002.269
V Zelenák, K Györyová, D Mlynarcík

The antibacterial and antifungal activity of zinc(II) carboxylates with composition Zn(RCOO)(2)*nH(2)O(R =H-, CH(3) (-), CH(3)CH(2)CH(2) (-), (CH(3))(2)CH-, XCH(2) (-), X=Cl, Br, I, n=0 or 2), [ZnX(2)(Nia(+)CH(2)COO(-))(2)](Nia=nicotinamide, X=Cl, Br, I) and [Zn(XCH(2)COO)(2)(Caf)(2)]*2H(2)O (Car=caffeine, X=Cl, Br) is studied against bacterial strains Staphylococcus aureus, Escherichia coli and yeast Candida albicans. The structural types are assigned to the prepared compounds and the influence of (i) carboxylate chain length, (ii) substitution of hydrogen atom of carboxylate by halogen and (iii) presence of N-donor organic ligands on the biological activity is discussed.

研究了组成为Zn(RCOO)(2)*nH(2)O(R =H-, CH(3) (-), CH(3) (2)CH(2) (-), (CH(3))(2)CH-, XCH(2) (-), X=Cl, Br, I, n=0或2),[ZnX(2)(Nia(+)CH(2)COO(-))(2))](Nia=烟酰胺,X=Cl, Br, I)和[Zn(XCH(2)COO (2)(Caf)(2)]*2H(2)O (Car=咖啡因,X=Cl, Br))对金黄色葡萄球菌、大肠杆菌和白色念珠菌的抑菌活性。对所制备化合物的结构类型进行了划分,并讨论了(i)羧酸盐链长、(ii)羧酸盐氢原子被卤素取代和(iii) n给体有机配体的存在对生物活性的影响。
{"title":"Antibacterial and Antifungal Activity of Zinc(II) Carboxylates With/Without N-Donor Organic Ligands.","authors":"V Zelenák,&nbsp;K Györyová,&nbsp;D Mlynarcík","doi":"10.1155/MBD.2002.269","DOIUrl":"https://doi.org/10.1155/MBD.2002.269","url":null,"abstract":"<p><p>The antibacterial and antifungal activity of zinc(II) carboxylates with composition Zn(RCOO)(2)*nH(2)O(R =H-, CH(3) (-), CH(3)CH(2)CH(2) (-), (CH(3))(2)CH-, XCH(2) (-), X=Cl, Br, I, n=0 or 2), [ZnX(2)(Nia(+)CH(2)COO(-))(2)](Nia=nicotinamide, X=Cl, Br, I) and [Zn(XCH(2)COO)(2)(Caf)(2)]*2H(2)O (Car=caffeine, X=Cl, Br) is studied against bacterial strains Staphylococcus aureus, Escherichia coli and yeast Candida albicans. The structural types are assigned to the prepared compounds and the influence of (i) carboxylate chain length, (ii) substitution of hydrogen atom of carboxylate by halogen and (iii) presence of N-donor organic ligands on the biological activity is discussed.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 5","pages":"269-74"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2002.269","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27437892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 52
Txicological Aspects of Newly Designed Macrocyclic Complexes of Iron(II). 新设计的铁大环配合物的毒理学研究(II)。
Pub Date : 2002-01-01 DOI: 10.1155/MBD.2002.315
Ashu Chaudhary, R V Singh

Brine shrimp lethality of a new series of 16 to 26-membered macrocycles of iron(II) containing tetraaza groups and prepared by the template condensation reaction of diacarboxylic acids (malonic, succinic, glutaric or adipic) with 2,6-diaminopyridine and diethylenetriamine in 1:2:2 molar ratios have been studied. Structures and bonding of the macrocyclic complexes have been proposed based on elemental analyses, IR, electronic, X-ray and mass spectral studies. An octahedral geometry for these complexes has been proposed as the binding sites are the nitrogen atoms of the macrocycles. The formation of the complexes as [Fe(L(n))Cl(2)] has been established on the basis of the chemical composition. The complexes have also been screened against several microbes.

研究了由二羧酸(丙二酸、丁二酸、戊二酸或己二酸)与2,6-二氨基吡啶和二乙烯三胺以1:2:2摩尔比的模板缩合反应制备的含有四氮杂基团的16 ~ 26元铁(II)大环对卤虾的致死性。基于元素分析、红外光谱、电子、x射线和质谱研究,提出了大环配合物的结构和键合。这些配合物的八面体结构已被提出,因为结合位点是大环的氮原子。根据化学组成确定了[Fe(L(n))Cl(2)]等配合物的形成。这些复合物还经过了几种微生物的筛选。
{"title":"Txicological Aspects of Newly Designed Macrocyclic Complexes of Iron(II).","authors":"Ashu Chaudhary,&nbsp;R V Singh","doi":"10.1155/MBD.2002.315","DOIUrl":"https://doi.org/10.1155/MBD.2002.315","url":null,"abstract":"<p><p>Brine shrimp lethality of a new series of 16 to 26-membered macrocycles of iron(II) containing tetraaza groups and prepared by the template condensation reaction of diacarboxylic acids (malonic, succinic, glutaric or adipic) with 2,6-diaminopyridine and diethylenetriamine in 1:2:2 molar ratios have been studied. Structures and bonding of the macrocyclic complexes have been proposed based on elemental analyses, IR, electronic, X-ray and mass spectral studies. An octahedral geometry for these complexes has been proposed as the binding sites are the nitrogen atoms of the macrocycles. The formation of the complexes as [Fe(L(n))Cl(2)] has been established on the basis of the chemical composition. The complexes have also been screened against several microbes.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 6","pages":"315-21"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2002.315","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27437899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
Metal-Based Drugs
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1